Close Menu
Home » c-Met

c-Met

Jan 18, 2016

Tumor Cell, Mouse Studies Suggest c-Met Expression as Predictor of PARP Inhibitor Resistance

Researchers believe that blocking c-Met and PARP1 may help patients with TNBC, and possibly other cancers, overcome resistance to PARP inhibitors.

Sep 02, 2009

Pfizer, Abbott Ink Deal to Develop Companion Dx for PGx-based NSCLC Drug

Premium

Pfizer has previously touted PF-02341066 as "the first agent in clinical development that selectively targets a unique genetic feature of cancer cells." The drug is currently in Phase III trials, while Abbott is in the process of designing validating trials for a companion test with the capability to detect ALK gene rearrangements.

The Scan

Letter Criticizes Actions

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

Even Earlier Edits?

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

For Everyone

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

Nature Studies Mystery of Remains Near Himalayan Lake, More

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.